PE20130808A1 - Derivados de cis-tetrahidro-espiro(ciclohexan-1,1'-pirido[3,4-b]indol)-4-amina - Google Patents

Derivados de cis-tetrahidro-espiro(ciclohexan-1,1'-pirido[3,4-b]indol)-4-amina

Info

Publication number
PE20130808A1
PE20130808A1 PE2013000150A PE2013000150A PE20130808A1 PE 20130808 A1 PE20130808 A1 PE 20130808A1 PE 2013000150 A PE2013000150 A PE 2013000150A PE 2013000150 A PE2013000150 A PE 2013000150A PE 20130808 A1 PE20130808 A1 PE 20130808A1
Authority
PE
Peru
Prior art keywords
cyclohexan
indol
tetrahidro
pirido
spiro
Prior art date
Application number
PE2013000150A
Other languages
English (en)
Inventor
Klaus Linz
Saskia Zemolka
Bert Nolte
Stefan Schunk
Hans Schick
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44315152&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20130808(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE20130808A1 publication Critical patent/PE20130808A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A DERIVADOS DE CIS-TETRAHIDRO-ESPIRO(CICLOHEXAN-1,1'-PIRIDO[3,4-B]INDOL)-4-AMINA, CARACTERIZADOS PORQUE COMPRENDEN COMPUESTOS DE FORMULA GENERAL (I), EN DONDE R1 ES HIDROGENO, CH3; R2 Y R3 SON H, HALOGENO; R4 Y R5 ES H, HALOGENO, ALQUILO C1-C3, ENTRE OTROS; Q1-Q2 FORMAN -CH2-, -CR6=CH-; R6 Y R7 SON H, JUNTOS FORMAN UN ANILLO DE CINCO ELEMENTOS SOBRE EL PUENTE -S-, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 2-(4-CLOROFENIL)-1-((1s,4s)-4-(DIMETILAMINO)-4-(3-FLUOROFENIL)-3',4'-DIHIDRO-ESPIRO[CICLOHEXAN-1,1'-PIRIDO[3,4-b]INDOL]-2'(9'H)-IL)ETANONA; BENZO[b]TIOFEN-2IL((1s,4s)-4-(DIMETILAMINO)-4-(3-FLUOROFENIL)-3',4'-DIHIDRO-ESPIRO[CICLOHEXAN-1,1'-PIRIDO[3,4-b]INDOL]-2'(9'H)-IL)METANONA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA FORMULACION FARMACEUTICA. DICHOS COMPUESTOS SON UTILES PARA EL TRATAMIENTO DEL DOLOR NEUROPATICO Y CRONICO.
PE2013000150A 2010-07-28 2011-07-27 Derivados de cis-tetrahidro-espiro(ciclohexan-1,1'-pirido[3,4-b]indol)-4-amina PE20130808A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10007822 2010-07-28

Publications (1)

Publication Number Publication Date
PE20130808A1 true PE20130808A1 (es) 2013-07-06

Family

ID=44315152

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013000150A PE20130808A1 (es) 2010-07-28 2011-07-27 Derivados de cis-tetrahidro-espiro(ciclohexan-1,1'-pirido[3,4-b]indol)-4-amina

Country Status (32)

Country Link
US (3) US20120029006A1 (es)
EP (2) EP2598503B1 (es)
JP (1) JP5898193B2 (es)
KR (1) KR101927054B1 (es)
CN (1) CN103025732B (es)
AR (1) AR082393A1 (es)
AU (1) AU2011285217B8 (es)
BR (1) BR112013003642A2 (es)
CA (1) CA2806633C (es)
CL (1) CL2013000266A1 (es)
CO (1) CO6650378A2 (es)
CY (2) CY1115186T1 (es)
DK (2) DK2740476T3 (es)
EC (1) ECSP13012409A (es)
ES (2) ES2474644T3 (es)
HK (1) HK1183660A1 (es)
HR (2) HRP20140569T1 (es)
HU (1) HUE042732T2 (es)
IL (1) IL223756A (es)
LT (1) LT2740476T (es)
MX (1) MX2013000751A (es)
NZ (1) NZ607529A (es)
PE (1) PE20130808A1 (es)
PL (2) PL2740476T3 (es)
PT (2) PT2598503E (es)
RS (2) RS53341B (es)
RU (1) RU2592283C2 (es)
SI (2) SI2740476T1 (es)
TR (1) TR201821273T4 (es)
TW (1) TWI582092B (es)
WO (1) WO2012013343A1 (es)
ZA (1) ZA201301505B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX360290B (es) 2013-03-15 2018-10-29 Gruenenthal Gmbh Cis-(e)-4-(3-fluorofenil)-2',3',4,9'-tetrahidro-n,n-dimetil-2'-(1 -oxo-3-fenil-2-propenil)-espiro[ciclohexan-1,1'[1h]-pirido[3,4-b] indol]-4-amina cristalina.
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
RS60855B1 (sr) 2016-01-13 2020-10-30 Gruenenthal Gmbh Derivati 8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana
RS60307B1 (sr) 2016-01-13 2020-07-31 Gruenenthal Gmbh Derivati 3-((hetero-)aril)-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekana
DK3402783T3 (da) 2016-01-13 2020-05-04 Gruenenthal Gmbh 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater
AR107358A1 (es) * 2016-01-13 2018-04-25 Gruenenthal Gmbh Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano
ES2797904T3 (es) 2016-01-13 2020-12-04 Gruenenthal Gmbh Derivados de 3-((hetero)aril)alquil-8-amino-2-oxo-1,3-diazaespiro-[4.5]-decano
PL3407888T3 (pl) 2016-01-26 2021-08-30 Intra-Cellular Therapies, Inc. Związki pirydopirolochinoksaliny, ich kompozycje i zastosowania
TW201832765A (zh) * 2017-02-24 2018-09-16 德商歌林達有限公司 膀胱內投藥用於治療膀胱痛之組合物
TW201908295A (zh) 2017-07-12 2019-03-01 德商歌林達有限公司 １，３－二氮雜－螺－［３．４］－辛烷衍生物
JP2019073493A (ja) 2017-10-17 2019-05-16 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング ヴルヴォディニアの治療
WO2020030777A1 (en) 2018-08-10 2020-02-13 Grünenthal GmbH Composition for treating urinary frequency and/or urinary urgency
US20220184072A1 (en) * 2019-04-04 2022-06-16 Intra-Cellular Therapies, Inc. Methods of treating neuropathic pain
JP2023508469A (ja) 2019-12-26 2023-03-02 ギルガメッシュ・ファーマシューティカルズ・インコーポレイテッド アリールシクロヘキシルアミン誘導体及び精神障害の処置におけるそれらの使用
RU2725197C1 (ru) * 2020-02-12 2020-06-30 федеральное государственное бюджетное образовательное учреждение высшего образования «Ижевская государственная медицинская академия» Министерства здравоохранения Российской Федерации Метод оценки висцеральной гиперчувствительности
MX2022010082A (es) 2020-02-18 2022-11-14 Gilgamesh Pharmaceuticals Inc Triptaminas especificas para usarse en el tratamiento de trastornos de estado de animo.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10323172A1 (de) 2003-05-22 2004-12-09 Ina-Schaeffler Kg Treiberstufe für ein Solenoidventil
DE10360792A1 (de) 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10360793A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102004019502A1 (de) 2004-04-22 2005-11-17 Rheinmetall Landsysteme Gmbh Munitionsmagazin
DE102004039382A1 (de) 2004-08-13 2006-02-23 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
US8425881B2 (en) 2005-03-18 2013-04-23 Colgate-Palmolive Company Antibacterial 3′,5-disubstituted 2,4′-dihydroxybiphenyl compounds, derivatives and related methods
DE102005016460A1 (de) * 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
EP1869344A2 (en) 2005-04-12 2007-12-26 The Ohio State University All wheel drive electrically-variable transmission
US20090246774A1 (en) 2006-03-30 2009-10-01 Mehar Singh Khatkar Chromosomal Blocks as Markers for Traits
WO2007117173A1 (en) 2006-04-07 2007-10-18 Closed Joint Stock Company 'biocad' Fluid dispensing system, methods and products
DE102006019597A1 (de) 2006-04-27 2007-10-31 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102006033114A1 (de) 2006-07-18 2008-01-24 Grünenthal GmbH Spirocyclische Azaindol-Derivate
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
WO2008100941A2 (en) 2007-02-12 2008-08-21 Correlogic Systems Inc. A method for calibrating an analytical instrument
MX2010009955A (es) * 2008-03-27 2010-09-30 Gruenenthal Gmbh Derivados de ciclohexano espirociclicos sustituidos.
MX360290B (es) * 2013-03-15 2018-10-29 Gruenenthal Gmbh Cis-(e)-4-(3-fluorofenil)-2',3',4,9'-tetrahidro-n,n-dimetil-2'-(1 -oxo-3-fenil-2-propenil)-espiro[ciclohexan-1,1'[1h]-pirido[3,4-b] indol]-4-amina cristalina.

Also Published As

Publication number Publication date
US20120029006A1 (en) 2012-02-02
KR20130098315A (ko) 2013-09-04
CY1120993T1 (el) 2019-12-11
ECSP13012409A (es) 2013-06-28
LT2740476T (lt) 2018-12-27
CL2013000266A1 (es) 2013-05-24
EP2598503B1 (de) 2014-03-26
HRP20182078T1 (hr) 2019-02-08
HRP20140569T1 (hr) 2014-08-15
JP5898193B2 (ja) 2016-04-06
HK1183660A1 (en) 2014-01-03
PL2740476T3 (pl) 2019-06-28
TR201821273T4 (tr) 2019-01-21
CN103025732B (zh) 2016-06-01
CA2806633C (en) 2019-08-20
IL223756A (en) 2015-06-30
CN103025732A (zh) 2013-04-03
BR112013003642A2 (pt) 2016-09-06
CO6650378A2 (es) 2013-04-15
PT2740476T (pt) 2019-03-18
ES2708930T3 (es) 2019-04-12
RS58036B1 (sr) 2019-02-28
ZA201301505B (en) 2014-08-27
ES2474644T3 (es) 2014-07-09
JP2013532669A (ja) 2013-08-19
RS53341B (en) 2014-10-31
NZ607529A (en) 2014-05-30
PL2598503T3 (pl) 2014-08-29
SI2740476T1 (sl) 2019-02-28
AU2011285217B8 (en) 2014-04-24
WO2012013343A1 (de) 2012-02-02
CY1115186T1 (el) 2017-01-04
KR101927054B1 (ko) 2018-12-10
AU2011285217A8 (en) 2014-04-24
US20160159787A1 (en) 2016-06-09
EP2740476A1 (de) 2014-06-11
CA2806633A1 (en) 2012-02-02
DK2598503T3 (da) 2014-04-14
SI2598503T1 (sl) 2014-05-30
AU2011285217B2 (en) 2014-04-10
RU2013108696A (ru) 2014-09-10
EP2740476B1 (de) 2018-12-05
MX2013000751A (es) 2013-01-29
DK2740476T3 (en) 2019-01-14
TWI582092B (zh) 2017-05-11
HUE042732T2 (hu) 2019-07-29
TW201204724A (en) 2012-02-01
RU2592283C2 (ru) 2016-07-20
US20170313703A1 (en) 2017-11-02
EP2598503A1 (de) 2013-06-05
AU2011285217A1 (en) 2013-03-14
AR082393A1 (es) 2012-12-05
PT2598503E (pt) 2014-05-06

Similar Documents

Publication Publication Date Title
PE20130808A1 (es) Derivados de cis-tetrahidro-espiro(ciclohexan-1,1'-pirido[3,4-b]indol)-4-amina
PE20170666A1 (es) 2-(morfolin-4-il)-1,7-naftiridinas
AR110069A2 (es) Composiciones antagonistas del receptor de cgrp
RU2018114289A (ru) Бициклические соединения в качестве ингибиторов аутотаксина (atx)
RU2404163C2 (ru) Производные 2,3,4,9-тетрагидро-1h-карбазола в качестве антагонистов рецептора crth2
ES2521596T3 (es) Combinación del compuesto GlyT1 con antipsicóticos
PE20070093A1 (es) Derivados dihidrobenzofuranos como moduladores del receptor 5-ht2c
HRP20171696T1 (hr) 3,4-dihidroizokinolin-2(1h)-ilni spojevi
JP2017524668A5 (es)
PE20060599A1 (es) DERIVADOS PIRAZOLO-[3,4-d]-PIRIMIDINA COMO INHIBIDORES DE LA ACTIVIDAD DEL RECEPTOR CANNABINOIDE 1
PE20180500A1 (es) Derivados de 2,3-dihidro-4h-1,3-benzoxazin-4-ona como moduladores del receptor muscarinico colinergico m1
PE20120534A1 (es) PIRIMIDINAS FUSIONADAS COMO INHIBIDORES DE Akt
JP2007531751A5 (ja) 血管運動症状（ｖｍｓ）の治療のためのノルエピネフリン（ｎｅ）およびセロトニン（５−ｈｔ）活性およびモノアミン再取り込みの調節物質としてのヘテロサイクリックフェニルプロパン−２−オール誘導体および関連化合物
JP2016516821A5 (es)
GEP20166472B (en) Androgen receptor modulating compounds
PE20120413A1 (es) ENANTIOMERO (S) DE 1'-{[5-(TRIFLUOROMETIL)FURAN-2-IL]METIL}ESPIRO[FURO[2,3-f][1,3]BENZODIOXOL-7,3'-INDOL]-2'(1'H)-ONA
PE20160844A1 (es) Compuestos triciclicos como agentes anticancerigenos
AR073314A1 (es) Derivados de indazol o de 4,5,6,7-tetrahidro-indazol
AR092955A1 (es) Antagonistas de receptores de orexina los cuales son derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)-pirrolidin-1-il]-metanona
AR067845A1 (es) Compuestos para tratar trastornos relacionados con la modulacion de receptores de rianodina y composicion farmaceutica
JP2009524676A5 (es)
AR071717A1 (es) Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer.
PE20210154A1 (es) Derivados de piridincarbonilo y usos terapeuticos de los mismos como inhibidores de trpc6
PE20070586A1 (es) Compuestos de (4-piperidinil)-1,3-dihidro-2h-bencimidazol-2-ona sustituidos como agonistas del receptor muscarinico m1
PE20080056A1 (es) Derivados de cromencarboxamida como antagonistas del receptor s1p1

Legal Events

Date Code Title Description
FG Grant, registration